Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro

British Journal of Cancer

Volumn 73, Issue 1, 1996, Pages 54-60

  Huschtscha, L I ^a   Bartier, W A ^a   Andersson Ross, C E ^b   Tattersall, M H N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Karobio Pty   (Sweden)

Author keywords

Apoptosis; Cell cycle; Cell death; Cytotoxic drugs

Indexed keywords

ANTINEOPLASTIC ALKALOID; CYTOTOXIC AGENT; DEXAMETHASONE; FLOXURIDINE; FLUOROURACIL; FOLIC ACID ANTAGONIST; GLUCOCORTICOID; METHOTREXATE; PYRIMIDINE ANTAGONIST; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL LINE; CELL STRUCTURE; DNA CLEAVAGE; DNA DEGRADATION; FLOW CYTOMETRY; GROWTH INHIBITION; PRIORITY JOURNAL;

EID: 0030024018     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.10     Document Type: Article

References (38)

1. ARENDS MJ AND WYLLIE AH. (1991). Apoptosis: mechanisms and roles in pathology. Int. Rev. Exp. Pathol. 32, 223-254.
2. ARENDS MJ, MORRIS RG AND WYLLIE AH. (1990). Apoptosis: the role of the endonuclease. Am. J. Pathol., 136, 593-608.
3. ASKEW DS, ASHMUN RA, SIMMONS BC, CLEVELAND JL. (1991). Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 6, 1915-1922.
4. BARRY MA, BEHNKE CA AND EASTMAN B. (1990). Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40, 2353-2362.
5. BISSONETTE RP, ECHEVERRI F, MAHBOUBI A AND GREEN DR. (1992). Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature, 359, 552-554.
6. CATCHPOOLE DR AND STEWART BW. (1993). Etoposide-induced cytotoxicity in 2 human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res., 53, 4287-4296.
7. CHENG J AND HAAS M. (1990). Frequent mutations in the p53 tumour suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol., 10, 5502-5509.
8. DIVE C AND HICKMAN JA. (1991). Drug-target interactions: only the first step in the commitment to a programmed cell death? Br. J. Cancer. 64, 192-196.
9. DIVE C, GREGORY CD, PHIPPS DJ, EVANS DL, MILNER AE AND WYLLIE AH. (1992). Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta. 1133, 275-285.
10. DYSON JED, SIMMONS DM, DANIEL J, MCLAUGLIN JM, QUIRKE P AND BIRD CC. (1986). Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia. Cell. Tissue Kinet., 19, 311-324.
11. FISHER TC, MILNER AE, GREGORY CD, JACKMAN AL, AHERNE GW, HARTLEY JA, DIVE C AND HICKMAN JA. (1993). bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res., 53, 3321-3326.
12. FOLEY GE, LAZARUS H, FARBER S, UZMAN BG, BOONE BA AND MCCARTHY RE. (1965). Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukaemia. Cancer, 18, 522-529.
13. GUNJI H, KHARBANDA S AND KUFE D. (1991). Induction of internuclcosomal DNA fragmentation in human myeloid leukaemia cells by 1-β-D-arabino-furanosyl-cytosine. Cancer Res., 51, 741-743, 1991.
14. HICKMAN JA. (1992). Apoptosis induced by anticancer drugs. Cancer Metasis Rev., 11, 121-139.
15. HOTZ MA, TRAGANOS F AND DARZYNKIEWICZ Z. (1992). Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerasc 11 inhibitor fostriecin in MOLT.4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. Exp. Cell Res., 201, 184-191.
16. HUSCHTSCHA LI, JEITNER TM, ANDERSSON CE, BARTIER WA AND TATTERSALL MHN. (1994). Identification of apoptotic and necrotic human leukaemic cells by flow cytometry. Exp. Cell Res., 212, 161-165.
17. HUSCHTSCHA LI, BARTIER WA, MALMSTROM A AND TATTERSALL MHN. (1995). Cell death by apoptosis following anticancer drug treatment in vitro. Int. J. Oncol. 6, 585-593.
18. KAMESAKI S, KAMESAKI H, JORGENSON TJ, TANIZAWA A, POMMIER Y AND COSSMAN J. (1993). bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res., 53, 4251-4256.
19. KAUFMANN SH. (1989). Induction of endonucleolytic DNA cleavage in human acute myelogenous leukaemia cells by eloposide, camptothecin and other cytotoxic anticancer drugs: A cautionary note. Cancer Res., 49, 5870-5878.
20. KERR JFR, SEARLE J, HARMON BV AND BISHOP CJ. (1987). Apoptosis. In Perspectives on Mammalian Cell Death. Potten CS (ed.) pp. 93-128. Oxford University Press.
21. KUNG AL, ZETTERBERG A, SHERWOOD SW AND SCHIMKE RT. (1990). Cytotoxic effects of cell cycle phase specific agents: results of cell cycle perturbation. Cancer Res., 50, 7307-7317.
22. LANE DP. (1992). Cancer. p53, guardian of the genome. Nature, 358, 15-16.
23. LENNON SV, MARTIN SJ AND COTTER TG. (1991). Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 24, 203-214.
24. LOWE SW, RULEY HE, JACKS T AND HOUSMAN DE. (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74, 957-967.
25. MCDOUGALL CA, KLUCK RM, HARMON BV, KERR JFR AND HALLIDAY JW. (1990). Is internucleosomal cleavage of DNA a reliable marker for apoptosis? Aust. Soc. Med. Res., 15, 51.
26. MARKS DI AND FOX RM. (1991). DNA damage, poly(ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action. Biochem. Pharmacol., 42, 1859-1867.
27. MILLER SA, DYKES DD AND POLESKY HF. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215.
28. OBERHAMMER F, WILSON JW, DIVE C, MORRIS ID, HICKMAN JA, WAKELING AC, WALKER PR AND SIKORSKA M. (1993). Apoptotic death in epithelial cells: cleavage of DNA to 300 and or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12, 3679-3684.
29. OLIVER FJ, MARVEL J, COLLINS MK AND LOPEZ-RIVAS A. (1993). bcl-2 oneogene protects a bone marrow-derived pre-B-cell line from 5′-fluoro-2′-deoxyuridine-induced apoptosis. Biochem. Biophys. Res. Commun., 194, 126-132.
30. RAFFRAY M AND COHEN GM. (1991). Bis (tri-n-butyllin)oxide induces programmed cell death (apoptosis) in immature rat thymocytes. Arch. Toxicol. 65, 135-139.
31. RUSSELL JC, HARMON BV, GOBE GC AND KERR JFR. (1992) Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int. J. Radiat. Biol., 61, 451-453.
32. SELVAKUMARAN M, LIN H-K, MIYASHITA T, WANG HG, KRAJEWSKI S, REED JC, HOFFMAN B AND LIEBERMANN D. (1994). Immediate early up-regulation of 'bax' expression by p53 but not TGFβ1: a paradigm for distinct apoptolic pathways. Oncogene, 9, 1791-1798.
33. SMETS LA. (1994). Programmed cell death (apoptosis) and response to anti-cancer drugs. Anticancer Drugs, 5, 3-9.
34. VEDECKIS WV AND BRADSHAW HD. (1983). DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents. Mol. Cell Endocrinol. 30, 215-227.
35. WALTON MI, WHYSONG D. O'CONNOR PM, HOCKENBERY D, KORSMEYER SJ AND KOHN KW. (1993). Constitutive expression of human bcl-2 modulates nitrogen mustard and eamptothecin induced apoptosis. Cancer Res., 53, 1853-1861.
36. WYLLIE AH. (1980). Glucocortieoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, 555-556.
37. WYLLIE AH. (1987). Cell death. Int. Rev. Cytol., 17, (Supp.) 755-785.
38. WYLLIE AH, KERR JFR AND CURRIE AR. (1980). Cell death: the significance of apoptosis. Int. Rer. Cytol., 68, 251-306.